The total return over the past 12 months is -69.24% vs. +16.94% for the S&P 500. So far it's up -77.11% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (69.24%) | (36.26%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (69.24%) | (36.26%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Context Therapeutics Inc. (CNTX)
| Year | Start price | End price | CNTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.47 | $0.34 | (77.11%) | +14.51% | (91.62%) |
| 2025 | $1.05 | $1.47 | +40.00% | +17.72% | +22.28% |
| 2024 | $1.13 | $1.05 | (7.08%) | +24.89% | (31.97%) |
| 2023 | $0.65 | $1.13 | +73.39% | +26.19% | +47.20% |
| 2022 | $2.66 | $0.65 | (75.50%) | (18.17%) | (57.33%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
